InMed Pharmaceuticals Inc. (INM)

CIK 1728328 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for InMed Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 202610-K0001213900-26-098419
Sep 9, 2026S-4/A0001193125-26-386611
Sep 9, 20264250001213900-26-098432
Aug 14, 2026SCHEDULE 13G0001193125-26-352958
Jul 22, 20264250001213900-26-080417
Jul 22, 20268-K0001213900-26-080414
Jul 22, 20264250001213900-26-080423
Jul 20, 20264250001213900-26-079635
Jul 17, 202640001940272-26-000010
Jul 16, 202640001213900-26-078891
Jul 10, 20268-K0001213900-26-077127
Jul 10, 20264250001213900-26-077132
Jul 2, 2026S-40001193125-26-294455
Jul 2, 202640001213900-26-075144
Jun 10, 20268-K0001062993-26-003132
Jun 10, 202640001213900-26-067505
Jun 10, 2026SCHEDULE 13D0001213900-26-067514
Jun 10, 202630001213900-26-067504
Jun 5, 2026SCHEDULE 13G0001104659-26-071020
May 27, 2026SCHEDULE 13G0002050709-26-000019
May 21, 202640001940272-26-000008
May 21, 202630001940272-26-000007
May 19, 20264250001213900-26-058800
May 19, 20268-K0001213900-26-058795
May 19, 20268-K0001062993-26-002787